# Fecal Microbiota Transplantation for Obese Women With Polyendocrine Metabolic Ovarian Syndrome

> **NCT07746635** · NA · RECRUITING · sponsor: **Shanghai Changzheng Hospital** · enrollment: 201 (estimated)

## Conditions studied

- PCOS (Polycystic Ovary Syndrome)

## Interventions

- **BIOLOGICAL:** oral Fecal Microbiota Transplantation
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07746635
- **Lead sponsor:** Shanghai Changzheng Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-15
- **Primary completion:** 2028-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 201 (ESTIMATED)
- **Last updated:** 2026-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07746635

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07746635, "Fecal Microbiota Transplantation for Obese Women With Polyendocrine Metabolic Ovarian Syndrome". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07746635. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*